Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-2

Pralmorelin, Growth Hormone Releasing Peptide-2, KP-102

A synthetic hexapeptide that mimics ghrelin to stimulate growth hormone release from the pituitary gland via GHS receptors.

Quick Stats
Studies 230
Trials 1
Formula C45H55N9O6
Clear All
Utility 2
pubmed Feb 8, 2019

β1-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress.

Gupta. Deepali D; Chuang. Jen-Chieh JC; Mani. Bharath K BK; Shankar. Kripa K; Rodriguez. Juan A JA;...

In stressed mice, the natural rise in the hunger hormone acyl‑ghrelin depends on β1‑adrenergic receptors. Blocking these receptors with atenolol stops the ghrelin increase and makes depressive‑like behavior worse. Giving extra acyl‑ghrelin or the synthetic GHSR agonist GHRP‑2 does not improve mood under chronic stress.

Utility 2
pubmed Jul 12, 2011

Doping control analysis of selected peptide hormones using LC-MS(/MS).

Thevis. Mario M; Thomas. Andreas A; Schänzer. Wilhelm W

The study shows that modern lab techniques (LC‑MS/MS) can now reliably spot peptide drugs like GHRP‑2, other growth‑hormone‑releasing peptides, insulins and IGF‑1 in blood or urine, even when they’re mixed together. It also explains new tools that make it easier to tell similar‑looking molecules apart.

Utility 2
pubmed Apr 17, 2010

Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.

Kimura. Takashi T; Shimatsu. Akira A; Arimura. Hiroshi H; Mori. Hideki H; Tokitou. Akinori A; Fukudo...

The study found that the peptide GHRP-2, which is known for boosting growth hormone, also directly triggers the release of ACTH (a hormone that tells the body to make cortisol) in people with pituitary problems, even when other stress tests don’t work.

Utility 2
pubmed Dec 12, 2024

Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model.

Li. Yinghao Y; Yao. Lei L; Zhang. Chunsen C; Li. Tao T; Wang. Duan D; Li. Jian J; Huang. Yizhou Y; T...

In rats, giving the peptide GHRP-2 after a rotator cuff tear lowered harmful inflammation and helped the tendon reattach to bone better, making the repair stronger and improving how the animals walked.

Utility 2
pubmed Nov 13, 2012

Metabolism of growth hormone releasing peptides.

Thomas. Andreas A; Delahaut. Philippe P; Krug. Oliver O; Schänzer. Wilhelm W; Thevis. Mario M

Scientists studied how the growth‑hormone‑releasing peptide GHRP‑2 (and similar short peptides) is broken down in the body and how to detect its waste products in urine. They gave the peptide to rats, mixed it with human blood, and used advanced mass‑spectrometry tools to map at least 28 different breakdown products. This work mainly helps anti‑doping labs spot illegal use, rather than telling users how to dose or what benefits to expect.

Utility 2
pubmed Nov 9, 2015

Ghrelin Receptor Ligands Reaching Clinical Trials: From Peptides to Peptidomimetics; from Agonists to Antagonists.

Vodnik. M M; Štrukelj. B B; Lunder. M M

The paper reviews all the ghrelin‑receptor drugs that have been made, including GHRP‑2. It says that, although many of these compounds have been tested in animals and some in people for things like boosting growth hormone, speeding stomach emptying, or fighting muscle loss, none have become approved medicines except that Japan lets GHRP‑2 be used as a diagnostic tool. New work is now looking at blockers of the same receptor to help with obesity.

Utility 2
pubmed Mar 4, 2014

Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice.

Zeng. Ping P; Li. Shu S; Zheng. Yue-hui YH; Liu. Fu-Yan FY; Wang. Jing-lei JL; Zhang. Da-lei DL; Wei...

In mice, injecting the ghrelin‑like peptide GHRP‑2 directly into the brain reduced pain. The pain‑relief depended on the ghrelin receptor and also involved certain opioid receptors, and GHRP‑2 boosted the effect of morphine. This points to a possible link between the ghrelin system and opioid‑mediated pain control, but the study used a brain injection method that isn’t practical for humans.

Utility 2
pubmed Nov 26, 2019

Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.

Soga. Akimi A; Fukuda. Izumi I; Kobayashi. Shunsuke S; Tahara. Shigeyuki S; Morita. Akio A; Sugihara...

In people with non‑functioning pituitary tumors, how much growth hormone (GH) spikes after a GHRP‑2 test tells you how badly the pituitary is damaged and whether GH levels are likely to bounce back after surgery.

Utility 2
pubmed 2010

Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.

Li. Guang G; Li. Jianguo J; Zhou. Qing Q; Song. Xuemin X; Liang. Hui H; Huang. Lili L

In a rat study, giving the ghrelin‑like peptide GHRP‑2 shortly before a severe bacterial toxin (LPS) reduced lung damage, swelling, and inflammatory chemicals. The protective effect was linked to blocking a key inflammation pathway (NF‑kB). This shows GHRP‑2 can dampen acute inflammation in a very specific, disease‑model setting.

Utility 2
pubmed Aug 19, 2016

Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells.

Chao. Yi-Ning YN; Sun. David D; Peng. Yen-Chun YC; Wu. Yuh-Lin YL

In lab tests on human ovarian cells, the synthetic ghrelin‑like peptide GHRP‑2 lowered inflammation markers that are usually turned on by a strong cell‑activating chemical. It did this by speeding up the breakdown of inflammatory proteins and by dampening several signaling pathways that drive inflammation.

Utility 2
pubmed 2009

Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.

Sakihara. Satoru S; Kageyama. Kazunori K; Matsumoto. Atsufumi A; Ikeda. Hidetoshi H; Tsushima. Yuko...

The report describes a single patient with Cushing's disease whose ACTH levels shot up dramatically after a standard GHRP‑2 test. The tumor had the GHRP‑2 receptor, suggesting the peptide can directly boost ACTH in certain pituitary tumors. For most people this isn’t a therapeutic finding, but it shows that GHRP‑2 can strongly affect the stress‑hormone axis.

Utility 2
pubmed Sep 21, 2023

Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19.

Kartchner. David D; McCoy. Kevin K; Dubey. Janhvi J; Zhang. Dongyu D; Zheng. Kevin K; Umrani. Rushda...

A big computer‑driven study scanned millions of papers and found that people who had COVID‑19 can develop stubborn high blood pressure. The analysis linked this to several hormone‑related pathways, and even flagged growth‑hormone‑releasing peptide‑2 (GHRP‑2) as one of many molecules that might be involved.

Utility 2
pubmed Jun 6, 2022

Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.

Suzuki. Sawako S; Ruike. Yutarou Y; Ishiwata. Kazuki K; Naito. Kumiko K; Igarashi. Katsushi K; Ishid...

The study shows that the GHRP‑2 test, which is normally used to check growth‑hormone levels, also triggers ACTH (the hormone that tells the adrenal glands to make cortisol). In people with pituitary problems, a weak ACTH response during the test flags secondary adrenal insufficiency, especially when growth‑hormone deficiency is severe.

Utility 2
pubmed Nov 6, 2014

Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency.

Tanaka. Toshiaki T; Hasegawa. Yukihiro Y; Yokoya. Susumu S; Nishi. Yoshikazu Y

In a study of short, pre‑pubertal children with growth‑hormone deficiency, a nasal spray of the GH‑releasing peptide GHRP‑2 raised the kids' own GH levels but did not make them grow taller after a year of treatment. The brief spikes in GH were too small to trigger the downstream growth signals needed for height gain.

Utility 2
pubmed Jul 30, 2010

Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.

Okano. Masato M; Sato. Mitsuhiko M; Ikekita. Ayako A; Kageyama. Shinji S

Scientists created a lab test that can spot the peptide GHRP‑2 (also called pralmorelin) and its breakdown product in urine at very low levels. They showed the test works well and that after an IV dose, both the original peptide and its metabolite show up in the urine of all volunteers.

Utility 2
pubmed May 1, 2002

Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?

Roh. Sang-Gun SG; Chen. Chen C; Choi. Ki-Choon KC; Shrestha. Yogendra Y; Sasaki. Shin-Ichi S

In rat pituitary cells, the study shows that the usual hormone (GHRH) needs its own receptor to trigger growth hormone release, but the peptide GHRP-2 can still cause some GH release even when that receptor is blocked, as long as its own receptor (GHS‑R) is present. Only when both receptors are knocked down does GH release stop completely.

Utility 2
pubmed Mar 1, 2020

Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.

Sinha. Deepankar K DK; Balasubramanian. Adithya A; Tatem. Alexander J AJ; Rivera-Mirabal. Jorge J; Y...

The review says that growth‑ hormone secretagogues (like GHRP‑2) can boost GH and IGF‑1, which might help men with low testosterone lose fat and keep muscle, but there aren’t many solid human studies yet.

Utility 2
pubmed Mar 9, 2020

Abundant expression of the membrane-anchored protease-regulator RECK in the anterior pituitary gland and its implication in the growth hormone/insulin-like growth factor 1 axis in mice.

Ogawa. Shuichiro S; Matsuzaki. Tomoko T; Noda. Makoto M

Researchers found that a protein called RECK, which sits on cell membranes in the pituitary gland, is important for making growth hormone (GH) and keeping the GH/IGF‑1 system working properly in mice. When RECK levels are lowered, mice get smaller, have less IGF‑1 in their blood, and show reduced GH production and fewer GH‑related receptors, even though the genes for those receptors are more active.